Ortega, A., Tarazón, E., Gil‐Cayuela, C., Martínez‐Dolz, L., Lago, F., González‐Juanatey, J. R., . . . Rivera, M. (2018). ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end‐stage heart failure patients. ESC Heart Fail.
Chicago ZitierstilOrtega, Ana, et al. "ASB1 Differential Methylation in Ischaemic Cardiomyopathy: Relationship With Left Ventricular Performance in End‐stage Heart Failure Patients." ESC Heart Fail 2018.
MLA ZitierstilOrtega, Ana, et al. "ASB1 Differential Methylation in Ischaemic Cardiomyopathy: Relationship With Left Ventricular Performance in End‐stage Heart Failure Patients." ESC Heart Fail 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.